Market Size (2019)
—
Vertical: AnDBase Year: 201910 Sections
Market Size (2019)
—
Projected (2027)
—
CAGR (2017–2027)
N/A
Key Players
9+
This report covers Nano Therapy Market with forecasts from 2017 to 2027. 9 key companies are profiled.
Nano Therapy Market is a key focus area for market intelligence and strategic research.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansNano therapy is a modern technique for treatment of various diseases and performed with the help of submicron sized molecular devices or nanoparticles. Nanotechnology offers the possibility to enhance drug dissolvability and strength, drag out medication half-lives in plasma, minimize off target impacts, and gather drugs at an objective site. This technology is characterized as submicron estimated atomic gadgets or nanoparticles prevalently running from 5 to 500 nm in one dimension.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansThe research starts with the extensive procurement process of data/information and statistics from company annual reports, government websites, statistics agencies, and paid databases. This information creates a base for the study. The information also helps to define the scope and to narrow down the area for study for the market. This raw information is processed and analyzed to extract crisp data points which currently affect or are likely to affect the industry during the forecast period. After analyzing the information, a proprietary statistical tool is used for market estimation and forecast, which generates the quantitative figures/sizes of the market/sub-segments in the current scenario as well as for the forecast period.
After estimating the market sizes and estimates, the numbers are verified with industry participants and key opinion leaders. The wide network of industry participants add value to the research and verify the numbers and estimates provided in the study. At the last stage of the research process, a final report is prepared, which is then published on different websites as well as distributed through various channels. The below figure contains the different stages of the research process to produce the report.
DATA MINING
Data mining is an extensive part of our research process. It involves the procurement of market data and related information from different verified and credible sources. This step helps to obtain raw information about the components of the industry and their deployment, the monetary process for different end uses, the pool of market participants, and the nature of the industry and scope of the study. The data mining stage comprises both primary and secondary sources of information.
SECONDARY RESEARCH
In the secondary research process, various sources are used to identify and gather industry trends and information for the research process. We at Wantstats have access to some of the most diversified and extensive paid databases, which give us the most accurate data/information on markets sizes, components, and pricing. Mentioned below is a detailed list of sources that have been used for this study. Please note that this list is not limited to the names as mentioned; we also access other data sources depending on the need.
Market Sizing & Revenue
Qualitative Information & Trends
Company Websites
· White Papers
· Magazines
· Company Websites
· Annual Reports
· Press Releases
· Investor Presentations
· Paid Databases
· Authenticated Directories
· Independent Studies
· Internal Audit Reports & Archives
· Government and Regulatory Published Material
· American Data Security Authority
· Nano therapy Advocacy Network.
· XXXXX
· XXXXX
Annual Reports
Investor Presentations
Authenticated Directories
Hoover’s, Factiva, Bloomberg
PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
Respondents
Data Points Received
Manufacturers
· Market Size
· Top of the Mind Key Market Players
· Direct Competitors
· Company Market Shares
· Growth Rate (%)
· Market Trends and Prominent Market Drivers
· Major Products
· Product Cost
· Commercial Availability
· Upcoming Technologies
End User
· Product Cost
· Adoption Rate & Maintenance Cost
BREAKDOWN OF PRIMARY RESPONDENTS
FORECASTING METHODS
We at Wantstats follow an extensive process for arriving at market estimations, which involves the use of multiple forecasting Methods as mentioned below.
Forecasting Methods
Description
Qualitative and Quantitative Analysis
A combination of qualitative approach, i.e., primary interviews with industry experts to understand the interviewees’ opinions and judgments, more commonly known as the Delphi method, and quantitative analysis to forecast future data based on historical and current data.
Weighted Average Approach
Via this approach, future data is calculated based on the mean of the past data under the assumption that some factors affecting the market in the past will continue to have a similar impact in the future.
Drift Method
This approach is used to vary the forecast, that is increase or decrease market factor over time depending on various parameters affecting the change in the trends of the market.
Time Series Methods
Integration of several time series methods such as moving average, moving weighted average, linear prediction, and trend estimation are applied while determining the year-on-year growth rate and the compound annual growth rate of the market being studied.
Causal/Econometric Forecasting Methods
Various economic factors such as inflation rate, fiscal policies, changes in government regulations, taxes, labour costs, and interest rates are taken into consideration while determining the current market size and predicting the future market growth rate.
Judgmental Methods
This involves collection of intuitive judgment, opinions, and probability estimates from industry experts in the case of new or upcoming markets/technologies for which no prior data is available.
Regression Analysis
This type of statistical modelling is carried out for predicting and forecasting dependent and independent variables that will directly or indirectly impact the market.
Probabilistic Forecasting
This forecasting method is carried out to assign a probability to every possible outcome ranging from the least optimistic to highly optimistic, which helps in gauging the market under stable conditions.
PESTLE Analysis
Political, economic, social, technological, legal, and environmental factors are taken into consideration while deriving the fluctuations in the growth rate of the market.
Porter’s Five Forces Analysis
By understanding the supplier-side and demand-side factors, the current market scenario can be estimated, and future market scenario predicted, which aid in deriving the growth rate of the market.
RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
Understanding and penetrating the market in terms of valuation is crucial task in the process of business research. This again becomes significantly important while investing and choosing the business opportunities. In this regard, we at Wantstats performs two ways market sizing approach simultaneously namely top-down and bottom-up approaches. In this step, we place different data points, numeric attributes, information and industry trends at an appropriate space to deduce the estimates & forecast values over the coming years. We use different mathematical models to estimate the market sizes of different economies and segments. Each of which is further summed up to define the total market.
We at Wantstats owns a proprietary statistical tool for market estimations which helps us to comprehend market size estimates & forecasts for different markets and industries.
In the bottom-up approach, the revenue of key companies and their shares in the market is assessed to deduce the market size. More than 80% key players operating in the nano therapy market is studied. The segmental revenue of each player is analyzed and the market size for nano therapy market is extracted from the segmental/product revenue with the help of secondary and primary research. This extracted market size for nano therapy market is then validated from industry experts and partner consultants. This derived market size contributes around 65 – 70% of the total global market share in terms of revenue for nano therapy market. Using the application of data triangulation method, the overall global market size is estimated.
TOP-DOWN APPROACH
This overall market size is then used in the top-down procedure to estimate the size of the other sub-markets with the help of percentage splits of the market segments from secondary and primary research. The demand side analysis is conducted in which spent analysis for major industries in each region is studied. The end-users considered in the scope of this research study contributes around 70 % of the total in the nano therapy market.
The countries considered in the scope of Nano therapy market are US, Canada, Mexico, the UK, Germany, France, Italy, Spain, Switzerland, Austria, Belgium, Denmark, Finland, Greece, Hungary, Italy, Luxembourg, the Netherlands, Norway, Poland, Portugal, Slovakia, Sweden, Romania, Ireland, China, Japan, Malaysia, Indonesia, the Philippines, South Korea, Singapore, India, Australia & New Zealand, South Africa, Egypt, Nigeria, Saudi Arabia, Qatar, the UAE, Bahrain, Kuwait, and Oman, Brazil, Argentina, Chile, and others. However, the number of countries vary from devices to devices and it solely depends on the product approvals in the respective countries and the commercial availability of the products.
Below figure explains the process of market estimation using independent tool employed by our analysts to get the sizing of the market.
Wantstats Analysis Overview
As a part of the market engineering, the both top-down and bottom-up approaches are utilized along with data triangulation models to derive and verify the market sizes and forecast over the coming years.
DATA TRIANGULATION
After arriving at the overall market sizes, the total market is divided into several segments and sub segments. Again, market breakdown and data triangulation procedures are implemented wherever applicable, to complete the overall market engineering process and to collect the exact statistics for all segments and sub-segments. The data was triangulated by studying various factors and trends from both demand and supply sides. Along with this, the market was validated by using both top-down and bottom-up approaches.
VALIDATION
Validation is the most important stage of the report making process. Validation via an intricately designed feedback process helps us to finalize the sizing estimates and forecast for the final collation. Extensive primary research is performed to verify the information. This includes telephonic & personal interviews, mails, feedback forms, questionnaires and polling options/answers with the group of relevant people. Validation helps to duly check the authenticity of the key industry trends, market dynamics, company market share, different business models & their conclusions.
Base Year
2019
Historical Period
2017 – 2018
Forecast Period
2020 – 2027
Primary Interviews
150+
Historical data (2017–2019) and forecast period (2019–2027)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
1.1 global Nano therapy Market: Company Share Analysis
Smith and Nephew
Selecta Biosciences, Inc
Sirnaomics, Inc
Tarveda Therapeutics
DIM
Cristal Therapeutics
CytImmune Science, Inc
NanoBio Corporation
Nanoprobes, Inc
Others
See plans for professionals or small and medium businesses.

Analytical insights on Nano Therapy Market covering market dynamics, competitive landscape, and strategic outlook.
Nano Therapy Market represents a significant market opportunity with multiple growth drivers across regions and segments.
Impact of Covid-19 on the Global Nano therapy Market
XX Impact on Supply Chain
XXXXX Impact on Production
XXXXXX Impact on Regions
XXXXX Demand-Supply Gap Analysis
XXXXXXX Impact on Pricing
XXXXXX
Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.
Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.
Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.
Profiles of 105 companies operating in the Nano Therapy Market market, including revenue, employee count, and market positioning where available.
Showing 105 of 105 companies
Smith and Nephew — AnD
DIM — AnD
NanoBio Corporation — AnD
Cristal Therapeutics — AnD
Tarveda Therapeutics — AnD
Olin is a vertically integrated North American chlor-alkali producer with three businesses: commodity chlorine chemistry, epoxy, and ammunition. It runs among the world's largest electrochemical-unit (ECU) capacity bases, chiefly at Freeport (Texas), Plaquemine (Louisiana), and McIntosh (Alabama). From that base it sells caustic soda, chlorine derivatives, and ethylene dichloride (EDC) and vinyl chloride monomer (VCM). It also feeds chlorine internally into one of the world's most integrated epoxy chains. Separately, its Winchester segment is one of the leading U.S. ammunition makers. Winchester operates the government-owned Lake City Army Ammunition Plant, which supplies most of the U.S. Army's small-calibre ammunition. After a record 2021–2022 super-cycle, earnings fell sharply. FY2025 adjusted EBITDA was $651.8M against $873.9M in FY2024. Causes included weak global chlor-vinyl and epoxy demand, subsidised Asian epoxy imports, and commercial ammunition destocking. Leverage rose to about 5x net debt/EBITDA by mid-2026. Management under CEO Ken Lane, in post since March 2024, has responded with a "value-first" commercial posture, the "Beyond250" structural cost programme, and now a transformational merger with Huntsman. The merger is intended to pair Olin's upstream chlorine molecules with Huntsman's downstream polyurethane and advanced-materials formulations. --- ### Company's own description (paraphrased from the FY2025 10-K, Item 1) Olin describes itself as a leading vertically integrated global manufacturer and distributor of chemical products and a leading U.S. ammunition manufacturer. All three segments are capital-intensive manufacturing businesses. ### Business model and revenue model Olin's revenue is almost entirely product revenue. There is no meaningful subscription or licensing income. The main exception is contracted U.S. military project revenue at Winchester, which is recognised over time on construction and modernisation work at Lake City. - **CAPV economics.** Chlorine and caustic soda are co-produced in fixed ratio as one "ECU" (about 1 tonne chlorine to about 1.1 tonnes caustic soda). Profitability depends on the combined ECU value, which in turn depends on: - caustic soda pricing (alumina, pulp and paper, water treatment, and chemicals demand), and - the value of chlorine outlets (EDC/VCM for PVC, chlorinated organics, epoxy, bleach, and hydrochloric acid). - **Olin's "value-first" strategy**, introduced under former CEO Scott Sutton in 2020–2021 and continued by Ken Lane, keeps ECU operating rates matched to demand rather than chasing volume. The aim is to protect price. - **Epoxy economics.** Margins depend on the spread between epoxy resin prices and benzene, propylene, and chlorine input costs. The segment has been structurally challenged by Asian (notably Chinese) export pricing since 2023. - **Winchester economics.** The business is a mix of: - cyclical, sentiment-driven commercial ammunition (sold to retailers, mass merchants, and distributors), and - contracted, stable military ammunition and Lake City project revenue. ### Value-chain position Olin sits upstream. It converts salt, electricity, ethylene, benzene, and propylene into commodity and intermediate chemicals. Its formulated epoxy solutions and Winchester branded ammunition are the only meaningful downstream activities. The Huntsman merger is explicitly designed to move the combined company downstream. Olin's chlorine and caustic would feed Huntsman's MDI/polyurethane, formulations, and advanced-materials chains (Olin/Huntsman merger release, 16 June 2026). ### Independent characterisation Olin is best understood as a levered, high-fixed-cost commodity chemicals platform with an embedded defence and consumer franchise. - **Cost advantage.** Its key competitive advantage is position on the North American cost curve: advantaged ethane-based ethylene, low-cost power contracts, and scale. This advantage remained intact through 2025. - **Product mix.** Its product mix has been the problem. The chain is long on EDC, an export commodity, and long on epoxy, a market Asian capacity has commoditised. - **Winchester's role.** Winchester was the stabiliser in 2023–2024, earning about $238–256M of segment income. It became a drag in 2025 (segment income $67.7M) as commercial demand normalised and copper and propellant costs spiked. - **Investment thesis.** The thesis now hinges on three things: the cycle trough in chlor-vinyls and epoxy, Beyond250 self-help, and Huntsman merger execution.
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Historical performance and future projections (2020–2030, USD Billion)